Principal Financial Group
GBT

Principal Financial Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Principal Financial Group’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,835
Closed -$1.15M – 2606
2022
Q3 		$1.15M Sell
16,835
-108
-0.6% -$5.96K ﹤0.01% 1820
2022
Q2 		$541K Sell
16,943
-27,686
-62% -$810K ﹤0.01% 2037
2022
Q1 		$1.55M Buy
44,629
+26,620
+148% +$796K ﹤0.01% 1906
2021
Q4 		$527K Sell
18,009
-6,892
-28% -$213K ﹤0.01% 2111
2021
Q3 		$635K Buy
24,901
+983
+4% +$28.9K ﹤0.01% 2111
2021
Q2 		$838K Buy
23,918
+3,646
+18% +$142K ﹤0.01% 2080
2021
Q1 		$826K Buy
20,272
+407
+2% +$18.7K ﹤0.01% 2034
2020
Q4 		$860K Sell
19,865
-324
-2% -$16K ﹤0.01% 1974
2020
Q3 		$1.11M Sell
20,189
-1,545
-7% -$98.2K ﹤0.01% 1851
2020
Q2 		$1.37M Buy
21,734
+5,264
+32% +$361K ﹤0.01% 1770
2020
Q1 		$842K Buy
16,470
+95
+0.6% +$6.36K ﹤0.01% 1762
2019
Q4 		$1.3M Sell
16,375
-635
-4% -$37.6K ﹤0.01% 1792
2019
Q3 		$825K Buy
17,010
+1,546
+10% +$80.6K ﹤0.01% 1853
2019
Q2 		$813K Buy
15,464
+651
+4% +$37.4K ﹤0.01% 1873
2019
Q1 		$784K Buy
14,813
+709
+5% +$34.8K ﹤0.01% 1862
2018
Q4 		$579K Sell
14,104
-2,728
-16% -$102K ﹤0.01% 1884
2018
Q3 		$639K Buy
16,832
+2,463
+17% +$109K ﹤0.01% 1923
2018
Q2 		$650K Buy
14,369
+1,405
+11% +$64K ﹤0.01% 1918
2018
Q1 		$626K Buy
12,964
+74
+0.6% +$4.13K ﹤0.01% 1910
2017
Q4 		$507K Buy
+12,890
New +$481K ﹤0.01% 1958

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Principal Financial Group's GBT Position: Q4 2022 in Review

Principal Financial Group sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 16,835 shares — an estimated $1.15M sold.

Principal Financial Group first reported a position in GBT in Q4 2017 and held it in 20 quarters. The position peaked at $1.55M in Q1 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Principal Financial Group reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Principal Financial Group sold 16,835 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.15M.
  • Principal Financial Group first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 20 quarters.
  • Principal Financial Group's Global Blood Therapeutics, Inc. position peaked at $1.55M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Principal Financial Group's 13F filing for Q4 2022, filed 9 Feb 2023.